BioSpace News Archive

Amry today announces that the US Food and Drug Administration (“FDA”) has granted Investigational New Drug (“IND”) clearance for AP101.

Macrophage Pharma Limited announced today the formation of an international Scientific Advisory Board (SAB).

DefiniGEN today announces the appointment of Professor Sir John Savill as a Non-Executive Director of the Board.

IDBS, a leader in enterprise scientific informatics platforms, today announced that Christian Marcazzo has joined the company as Vice President and General Manager, effective immediately.

It was a win for the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University, as a federal court of appeals ruled against the University of California (UC) on CRISPR patents.

Although the dominant story in biopharma patent litigation was the federal appeals court backing the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University over the University of California (UC) on CRISPR patents, there have been other patent decisions of note today as well. Let’s take a look.

Shares of Indiana-based Endocyte have slipped more than 3 percent this morning after the company announced the U.S. Food and Drug Administration accepted radiographic progression-free survival as an alternative primary endpoint in its Phase III VISION trial.

Even if you think networking just “isn’t your thing,” you can’t deny the power it holds to help you land the job you want.

Oxurion NV launches new global website showcasing its comprehensive drug development approach and diverse portfolio of next-generation therapies for back of the eye disease

AAFA Applauds Walgreens and Kaléo Partnership, Increasing Patient Access to Life-Saving Epinephrine